Capstone Holding Corp. 8-K

What Happened
Capstone Holding Corp. (ticker: CAPS) announced it received a Nasdaq Listing Qualifications deficiency letter on January 7, 2026, notifying the company that the closing bid price of its common stock has been below the $1.00 minimum required by Nasdaq Listing Rule 5550(a)(2) for the last 30 consecutive business days. The letter does not immediately affect the listing and CAPS will continue to trade on The Nasdaq Capital Market.

Key Details

• Nasdaq deficiency letter dated January 7, 2026; closing bid price under $1.00 for 30 consecutive business days.
• Company has 180 calendar days (until July 6, 2026) to regain compliance.
• To cure, the bid must close at $1.00 or more for at least 10 consecutive business days; Nasdaq will then confirm compliance in writing.
• If not cured by July 6, 2026, Capstone may be eligible for an additional 180-day period only if it meets market value of publicly held shares and other initial listing standards (except the minimum bid rule) and notifies Nasdaq of its intent to cure.

Why It Matters
A sustained closing bid below $1.00 puts Capstone at risk of delisting from Nasdaq if it cannot meet the specified cure conditions. Continued listing allows trading to persist for now, but investors should be aware of the timeline (July 6, 2026) and the potential for further Nasdaq action if the company fails to regain compliance. The company said it will monitor the stock price and consider options to regain compliance but provided no assurance it will succeed.